Novo Nordisk ASHAM:NOVA +1.13%82 Days Inventory is 338.92 as of Mar. 2026, which is 14% above its 10-year median of 296.10. GuruFocus rates HAM:NOVA with a GF Score™ of 82/100 and a GF Value™ of €119.41 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 918 Drug Manufacturers companies, Novo Nordisk AS ranks worse than 82.46% on this metric.
The historical rank and industry rank for Novo Nordisk AS's Days Inventory or its related term are showing as below:
HAM:NOVA'
s Days Inventory Range Over the Past 10 Years
Min: 280.86 Med: 296.1 Max: 328.48
Current: 290.77
During the past 13 years, Novo Nordisk AS's highest Days Inventory was 328.48. The lowest was 280.86. And the median was 296.10.
HAM:NOVA's Days Inventory is ranked worse than 82.46% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs HAM:NOVA: 290.77
Novo Nordisk AS's Days Inventory
increased
from Mar. 2025 (296.29) to Mar. 2026 (338.92).
It might indicate that Novo Nordisk AS's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Novo Nordisk AS's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.27.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Novo Nordisk AS's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.52.
Novo Nordisk AS (HAM:NOVA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Novo Nordisk AS's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Novo Nordisk AS's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Novo Nordisk AS Days Inventory Related Terms
Novo Nordisk AS Days Inventory Historical Data
* Premium members only.
The historical data trend for Novo Nordisk AS's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:NOVA vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Novo Nordisk AS's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novo Nordisk AS Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Novo Nordisk AS's Days Inventory distribution charts can be found below:
* The bar in red indicates where Novo Nordisk AS's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novo Nordisk AS (HAM:NOVA) has a Days Inventory of 338.92 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Novo Nordisk AS and its competitors. This is 14% above median its historical median of 296.10. Over the past decade, Novo Nordisk AS's Days Inventory has ranged from 280.86 to 328.48. According to the industry distribution chart, Novo Nordisk AS ranks #757 out of 918 companies in the Drug Manufacturers industry, placing it in the top 82.5%.
Is Novo Nordisk AS's Days Inventory too high?
Novo Nordisk AS's current Days Inventory of 338.92 is 14% above median its 10-year median of 296.10. Over the past 10 years, this metric has ranged from a low of 280.86 to a high of 328.48. The Drug Manufacturers industry median Days Inventory is 164.43. Novo Nordisk AS's value of 338.92 is 106.1% above this industry median. Based on the distribution chart, Novo Nordisk AS ranks #757 out of 918 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Novo Nordisk AS has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Novo Nordisk AS's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Novo Nordisk AS ranks #757 out of 918 companies for Days Inventory. This places Novo Nordisk AS in the lower half of its industry. The industry median Days Inventory is 164.43. Novo Nordisk AS's value of 338.92 is 106.1% above this benchmark. Historically, Novo Nordisk AS's own Days Inventory has ranged from 280.86 to 328.48 over the past decade. While the company's 10-year median is 296.10 vs. the industry median of 164.43, Novo Nordisk AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novo Nordisk AS's current Days Inventory of 338.92 is 106.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Novo Nordisk AS and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novo Nordisk AS's current Days Inventory is 338.92, which is 14% above median its own 10-year median of 296.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novo Nordisk AS stock overvalued right now?
Based on GuruFocus' analysis, Novo Nordisk AS (HAM:NOVA) is currently considered Significantly Undervalued. The stock's GF Value™ is €119.41, compared to a current price of €42.80 — trading 64.2% below its estimated fair value. The current Days Inventory is 338.92, which is 14% above median its 10-year median of 296.10 and 106.1% above the Drug Manufacturers industry median of 164.43. Novo Nordisk AS's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Novo Nordisk AS (HAM:NOVA), the current Days Inventory is 338.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novo Nordisk AS (HAM:NOVA) Overvalued in 2026?
Based on GuruFocus' analysis, Novo Nordisk AS stock appears to be undervalued.
The current stock price of €42.80 is trading 64.2% below its estimated GF Value™ of €119.41.
GuruFocus considers Novo Nordisk AS to be Significantly Undervalued.
Key valuation signals for HAM:NOVA:
Days Inventory: 338.92 (14% above median its 10-year median of 296.10)
GF Value™: €119.41 vs. price of €42.80 (64.2% below fair value)
Industry Position: 106.1% above the Drug Manufacturers median (#757 of 918)
No single metric tells the full story. See the HAM:NOVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
82GF Score
Get the complete analysis for HAM:NOVA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:NOVA has been successfully added to your 
